Professor Andrew Martin
Professorial Research Fellow
UQ Centre for Clinical Research
Professorial Research Fellow
Pro-Vice-Chancellor (Research Infrastructure)
Researcher biography
Andrew Martin is inaugural Professor of Innovative Clinical Trials and leads the University of Queensland's cLinical Trials cApability (ULTRA) program. Andrew was Professor in the biostatistics group at the NHMRC Clinical Trials Centre University of Sydney. He maintains that role in an honorary capacity since joining UQ. Prior to academia, Andrew held senior biostatistics roles within research-based pharmaceutical organisations (Pfizer and Roche).
Grants
Category 1: $14.3M Category 3: $131.8M
Grants: 2023 Clinical Trials and Cohort Studies Grant ID 2032441 ($1,362,000): P3BEP Trial - Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours; 2022 NHMRC Partnership Projects Grant 2015773 ($1,166,592): Strengthening healthcare systems with Patient Reported Outcome Measures (PROMs); 2020 CA ($600,000): Immuno-metabolic biomarkers for metastatic prostate cancer treatment response; 2018 MRFF Grant APP1170066 ($1,596,631): WHEAT Study on reducing NEC in preterm infants; 2018 CA Grant APP1158397 ($479,375): SCORE trial for shared colorectal cancer care; 2018 CA Grant APP1159837 ($600,000): P3BEP Trial for advanced germ cell tumours; 2018 NHMRC Project Grant APP1159787 ($1,587,163): BCG+MM Trial for bladder cancer; 2016 Victorian Cancer ($300,000): SCORE project on shared care of Colorectal cancer survivors; 2015 CA Priority-driven Collaborative Cancer Research Scheme ($443,307): LEAD - Lung cancer diagnostic and treatment pathways; 2015 NHMRC Project Grant 1108328 ($624,824): Oral Nicotinamide for skin cancer chemoprevention after Transplant; 2014 Co-funded Grant 1079794 ($597,095): Methoxyflurane to reduce discomfort of prostate biopsy; 2013 NHMRC Project Grant 1064121 ($880,425): CHEST Australia project for quicker primary care consultations in lung cancer; 2012 NHMRC Project Grant APP1047100 ($2,203,171): Bovine lactoferrin study on low birthweight infants; 2011 National Breast Cancer Foundation ($199,606): Physical well-being for metastatic breast cancer; 2011 NHMRC Project Grant 1028555 ($187,018): Evidence on reduced child obesity rates; 2011 NHMRC Project Grant 1026977 ($586,691): Oral nicotinamide for skin cancer prevention; 2011 Australasian College of Dermatologists grant ($25,000): Nicotinamide for non-melanoma skin cancer in renal transplant recipients; 2010 NHMRC Project Grant 1007628 ($369,208): NEU-HORIZONS study on riluzole for oxaliplatin neurotoxicity; 2010 NHMRC Project Grant 1003414 ($564,410): Phase II prostate cancer follow-up trial in primary care.
Statistical lead on the following projects receiving industry funding with USyd as administering institution: ENZARAD NCT02446444 ($12,178,000); ENZAMET NCT02446405 ($20,408,129); INTEGRATE ACTRN12612000239864 ($6,900,000); INTEGRATE IIa ACTRN12616000420448 ($22,264,248); INTEGRATE IIb NCT04879368 ($36,330,215); DASL-HiCaP NCT04136353 ($33,777,579).
Journal Articles
Pillay, Kineshta, Finlay, Warren H. and Martin, Andrew R. (2024). Understanding regional aerosol deposition in pediatric airways during oral breathing: Insights from computational modeling. Journal of Aerosol Science, 182 106438, 106438. doi: 10.1016/j.jaerosci.2024.106438
Pillay, Kineshta, Marr, Linsey C., Henriques, Andre, Martin, Andrew R., Prussin, Aaron J., Aleixo, Luis, Andreini, Marco, Mounet, Nicolas, Finlay, Warren H. and Tang, Julian W. (2024). Can we use viral receptor mapping and particle deposition models to predict the clinical severity of novel airborne pathogens?. Clinical Microbiology and Infection. doi: 10.1016/j.cmi.2024.11.005
Pavlakis, Nick, Shitara, Kohei, Sjoquist, Katrin, Martin, Andrew, Jaworski, Anthony, Tebbutt, Niall, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Chris, Strickland, Andrew, Rha, Sun Young, Lee, Keun-Wook, Kim, Jin-Soo, Bai, Li-Yuan, Hara, Hiroki, Oh, Do-Youn, Yip, Sonia, Zalcberg, John, Price, Tim, Simes, John and Goldstein, David (2024). INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer. Journal of Clinical Oncology. doi: 10.1200/jco.24.00055
Soon, Yu Yang, Marschner, Ian C., Schou, Manjula, Hofman, Michael S., Emmett, Louise, Davis, Ian D., Stockler, Martin R. and Martin, Andrew J. (2024). Lu-177 PSMA vs Comparator Treatments and Survival in Metastatic Castration-Resistant Prostate Cancer. JAMA Network Open, 7 (9) ARTN e2433863, e2433863. doi: 10.1001/jamanetworkopen.2024.33863
Sharifi, Nima, Diaz, Robert, Lin, Hui-Ming, Roberts, Evan, Horvath, Lisa G., Martin, Andrew, Stockler, Martin R., Yip, Sonia, Subhash, Vinod V., Portman, Neil, Davis, Ian D. and Sweeney, Christopher J. (2024). Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance. Journal of Clinical Investigation, 134 (18) e183583, 1-9. doi: 10.1172/jci183583
Soon, Yu Yang, Marschner, Ian C., Schou, Manjula, Sweeney, Christopher J., Davis, Ian D., Stockler, Martin R. and Martin, Andrew J. (2024). Challenges of estimating treatment effects after a positive interim analysis. European Journal of Cancer, 209 114230, 114230. doi: 10.1016/j.ejca.2024.114230
Nahm, Sharon H., Stockler, Martin R., Martin, Andrew J., Grimison, Peter, Fox, Peter, Zielinski, Rob, Hawson, Geoffrey AT., Tattersall, Martin HN. and Kiely, Belinda E. (2024). Correction to: Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals (Supportive Care in Cancer, (2022), 30, 9, (7763-7772), 10.1007/s00520-022-07167-3). Supportive Care in Cancer, 32 (6) 386. doi: 10.1007/s00520-024-08597-x
Emmett, Louise, Subramaniam, Shalini, Crumbaker, Megan, Nguyen, Andrew, Joshua, Anthony M., Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn J., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Gedye, Craig, Rutherford, Natalie K., Sandhu, Shahneen, Kumar, Aravind Ravi, Pook, David, Ramdave, Shakher, Nadebaum, David P., Voskoboynik, Mark, Redfern, Andrew D., Macdonald, William, Krieger, Laurence, Schembri, Geoff, Chua, Wei, Lin, Peter, Horvath, Lisa, Bastick, Patricia ... Davis, Ian D. (2024). [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial. The Lancet Oncology, 25 (5), 563-571. doi: 10.1016/s1470-2045(24)00135-9
Gafita, Andrei, Martin, Andrew J., Emmett, Louise, Eiber, Matthias, Iravani, Amir, Fendler, Wolfgang P., Buteau, James, Sandhu, Shahneen, Azad, Arun A, Herrmann, Ken, Stockler, Martin R., Davis, Ian D. and Hofman, Michael S. (2024). Validation of prognostic and predictive models for therapeutic response in patients treated with [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a post hoc analysis from a randomised, open-label, phase 2 trial. European Urology Oncology. doi: 10.1016/j.euo.2024.03.009
Hofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Buteau, James P., Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Ng, Siobhan, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Redfern, Andrew D., Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Yan, Stockler, Martin R., Williams, Scott G. ... Yip, Sonia (2024). Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. The Lancet Oncology, 25 (1), 99-107. doi: 10.1016/s1470-2045(23)00529-6
Gore, Claire, Lisy, Karolina, O’Callaghan, Clare, Wood, Colin, Emery, Jon, Martin, Andrew, De Abreu Lourenco, Richard, Schofield, Penelope and Jefford, Michael (2024). Colorectal cancer survivors' experiences and views of shared and telehealth models of survivorship care: a qualitative study. Psycho-Oncology, 33 (1) e6265. doi: 10.1002/pon.6265
Cho, Doah, Lord, Sarah J., Ward, Robyn, IJzerman, Maarten, Mitchell, Andrew, Thomas, David M., Cheyne, Saskia, Martin, Andrew, Morton, Rachael L., Simes, John and Lee, Chee Khoon (2024). Criteria for assessing evidence for biomarker-targeted therapies in rare cancers—an extrapolation framework. Therapeutic Advances in Medical Oncology, 16, 1-20. doi: 10.1177/17588359241273062
Sabz, Mozhgan, MacLean, Joanna, Martin, Andrew R. and Rouhani, Hossein (2024). Characterization of Wearable Respiratory Sensors for Breathing Parameter Measurements. IEEE Sensors Journal, 24 (20), 32283-32290. doi: 10.1109/jsen.2024.3448539
Nahm, Sharon H., Martin, Andrew J., Clayton, Josephine M., Grimison, Peter, Moth, Erin B., Pavlakis, Nick, Sjoquist, Katrin, Smith-Uffen, Megan E. S., Tognela, Annette, Vasista, Anuradha, Stockler, Martin R. and Kiely, Belinda E. (2023). Accuracy of oncologists' estimates of expected survival time in advanced cancer. JNCI Cancer Spectrum, 7 (6) pkad094. doi: 10.1093/jncics/pkad094
Jefford, Michael, Emery, Jon D., James Martin, Andrew, De Abreu Lourenco, Richard, Lisy, Karolina, Grunfeld, Eva, Mohamed, Mustafa Abdi, King, Dorothy, Tebbutt, Niall C., Lee, Margaret, Mehrnejad, Ashkan, Burgess, Adele, Marker, Julie, Eggins, Renee, Carrello, Joseph, Thomas, Hayley and Schofield, Penelope (2023). SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. eClinicalMedicine, 66 102346, 1-11. doi: 10.1016/j.eclinm.2023.102346
Sjoquist, Katrin M., Martin, Andrew, Pavlakis, Nick, Goldstein, David, Tsobanis, Eric, Moses, Daniel, Maher, Richard, Hague, Wendy, Gebski, Val, Stockler, Martin R. and Simes, R. John (2023). Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer. Journal of Cancer Research and Clinical Oncology, 149 (8), 4959-4965. doi: 10.1007/s00432-022-04404-4
Sweeney, Christopher J, Martin, Andrew J, Stockler, Martin R, Begbie, Stephen, Cheung, Leanna, Chi, Kim N, Chowdhury, Simon, Frydenberg, Mark, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, Martin Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Winter, Diana, Yip, Sonia, Zhang, Alison Y ... Thomas, Carys (2023). Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. The Lancet Oncology, 24 (4), 323-334. doi: 10.1016/S1470-2045(23)00063-3
Allen, Nicholas C., Martin, Andrew J., Snaidr, Victoria A., Eggins, Renee, Chong, Alvin H., Fernandéz-Peñas, Pablo, Gin, Douglas, Sidhu, Shireen, Paddon, Vanessa L., Banney, Leith A., Lim, Adrian, Upjohn, Edward, Schaider, Helmut, Ganhewa, Aparna D., Nguyen, Jennifer, Mckenzie, Catriona A., Prakash, Saurabh, Mclean, Catriona, Lochhead, Alistair, Ibbetson, Jan, Dettrick, Andrew, Landgren, Anthony, Allnutt, Katherine J., Allison, Clare, Davenport, Rachael B., Mumford, Blake P., Wong, Brittany, Stagg, Brendan, Tedman, Alexander ... Damian, Diona L. (2023). Nicotinamide for skin-cancer chemoprevention in transplant recipients. New England Journal of Medicine, 388 (9), 804-812. doi: 10.1056/NEJMoa2203086
Lam, Lyn Ley, Pavlakis, Nick, Shitara, Kohei, Sjoquist, Katrin M., Martin, Andrew J., Yip, Sonia, Kang, Yoon-Koo, Bang, Yung-Jue, Chen, Li-Tzong, Moehler, Markus, Bekaii-Saab, Tanios, Alcindor, Thierry, O’Callaghan, Christopher J., Tebbutt, Niall C., Hague, Wendy, Chan, Howard, Rha, Sun Young, Lee, Keun-Wook, Gebski, Val, Jaworski, Anthony, Zalcberg, John, Price, Timothy, Simes, John and Goldstein, David (2023). INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). BMC Cancer, 23 (1) 180, 1-12. doi: 10.1186/s12885-023-10642-7
Pathmanandavel, Sarennya, Crumbaker, Megan, Ho, Bao, Yam, Andrew O., Wilson, Peter, Niman, Remy, Ayers, Maria, Sharma, Shikha, Hickey, Adam, Eu, Peter, Stockler, Martin, Martin, Andrew J., Joshua, Anthony M., Nguyen, Andrew and Emmett, Louise (2023). Evaluation of 177Lu-PSMA SPECT quantitation as a response biomarker within a prospective 177Lu-PSMA-617 and NOX66 combination trial (LuPIN). Journal of Nuclear Medicine, 64 (2), 221-226. doi: 10.2967/jnumed.122.264398
Schmults, Chrysalyne D., Jambusaria-Pahlajani, Anokhi, Ruiz, Emily, Trepanowski, Nicole, Kim, Daniel Y., Hartman, Rebecca I., Allen, Nicholas C., Martin, Andrew J. and Damian, Diona L. (2023). Nicotinamide for Skin-Cancer Chemoprevention in Transplantation. New England Journal of Medicine, 388 (26), 2493-2495. doi: 10.1056/NEJMc2303841
Pathmanandavel, Sarennya, Crumbaker, Megan, Nguyen, Andrew, Yam, Andrew O., Wilson, Peter, Niman, Remy, Ayers, Maria, Sharma, Shikha, Eu, Peter, Martin, Andrew J., Stockler, Martin R., Joshua, Anthony M. and Emmett, Louise (2023). The Prognostic Value of Posttreatment 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN). Journal of Nuclear Medicine, 64 (1), 69-74. doi: 10.2967/jnumed.122.264104
Marschner, Ian C., Schou, Manjula and Martin, Andrew J. (2022). Estimation of the treatment effect following a clinical trial that stopped early for benefit. Statistical Methods in Medical Research, 31 (12), 2456-2469. doi: 10.1177/09622802221122445
Coskinas, Xanthi, Simes, R. John and Martin, Andrew J. (2022). Changes to design and analysis elements of research plans during randomised controlled trials in Australia. Medical Journal of Australia, 217 (10), 526-531. doi: 10.5694/mja2.51715
Buteau, James P, Martin, Andrew J, Emmett, Louise, Iravani, Amir, Sandhu, Shahneen, Joshua, Anthony M, Francis, Roslyn J, Zhang, Alison Y, Scott, Andrew M, Lee, Sze-Ting, Azad, Arun A, McJannett, Margaret M, Stockler, Martin R, Williams, Scott G, Davis, Ian D, Hofman, Michael S, Akhurst, Tim, Alipour, Ramin, Banks, Patricia, Beaulieu, Alexis, Chua, Wei, Dhiantravan, Nattakorn, Ford, Kate, Gedye, Craig, Goh, Jeffrey C, Guminski, Alex, Hamid, Anis, Haskali, Mohammad B, Hicks, Rodney J ... for the TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2022). PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. The Lancet Oncology, 23 (11), 1389-1397. doi: 10.1016/S1470-2045(22)00605-2
Balegar, Kiran Kumar V., Jayawardhana, Madhuka, Martin, Andrew J., de Chazal, Philip and Nanan, Ralph Kay Heinrich (2022). Hierarchical improvement of regional tissue oxygenation after packed red blood cell transfusion. PLoS One, 17 (7 July) e0271563. doi: 10.1371/journal.pone.0271563
Nahm, Sharon H., Stockler, Martin R., Martin, Andrew J., Grimison, Peter, Fox, Peter, Zielinski, Rob, Hawson, Geoffrey At., Tattersall, Martin Hn. and Kiely, Belinda E. (2022). Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals. Supportive Care in Cancer, 30 (9), 7763-7772. doi: 10.1007/s00520-022-07167-3
Hayne, Dickon, Grummet, Jeremy, Espinoza, David, McCombie, Steve P., Chalasani, Venu, Ford, Kate S., Frydenberg, Mark, Gilling, Peter, Gordon, Barbara, Hawks, Cynthia, Konstantatos, Alex, Martin, Andrew J., Nixon, Anthony, O’Brien, Colin, Patel, Manish I., Sengupta, Shomik, Shahbaz, Shekib, Subramaniam, Shalini, Williams, Scott, Woo, Henry H., Stockler, Martin R., Davis, Ian D. and Buchan, Nick (2022). ‘Pain-free TRUS B’: a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501). BJU International, 129 (5), 591-600. doi: 10.1111/bju.15552
Stockler, Martin R., Martin, Andrew J., Dhillon, Haryana M., Davis, Ian D. and Sweeney, Christopher J. (2022). Reply to L. Marandino et al. Journal of Clinical Oncology, 30 (19) JCO.22.00497, 2176-2177. doi: 10.1200/JCO.22.00497
Pathmanandavel, Sarennya, Crumbaker, Megan, Yam, Andrew O., Nguyen, Andrew, Rofe, Christopher, Hovey, Elizabeth, Gedye, Craig, Kwan, Edmond M., Hauser, Christine, Azad, Arun A., Eu, Peter, Martin, Andrew J., Joshua, Anthony M. and Emmett, Louise (2022). 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial. Journal of Nuclear Medicine, 63 (4), 560-566. doi: 10.2967/jnumed.121.262552
Stockler, Martin R., Martin, Andrew J., Davis, Ian D., Dhillon, Haryana M., Begbie, Stephen D., Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy R., Pook, David W., Reaume, M. Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G., Winter, Diana G. ... Sweeney, Christopher J. (2022). Health-related quality of life in metastatic, hormone-sensitive prostate cancer: ENZAMET (ANZUP 1304), an international, randomized phase III trial led by ANZUP. Journal of Clinical Oncology, 40 (8), 837-846. doi: 10.1200/JCO.21.00941
Robledo, Kristy P, Tarnow-Mordi, William O, Rieger, Ingrid, Suresh, Preeti, Martin, Andrew, Yeung, Carbo, Ghadge, Alpana, Liley, Helen G, Osborn, David, Morris, Jonathan, Hague, Wendy, Kluckow, Martin, Lui, Kei, Soll, Roger, Cruz, Melinda, Keech, Anthony, Kirby, Adrienne, Simes, John, on behalf of the APTS Childhood Follow-up Study collaborators and Gardener, Glenn (2022). Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a multicentre, randomised clinical trial. The Lancet Child and Adolescent Health, 6 (3), 150-157. doi: 10.1016/S2352-4642(21)00373-4
Seidler, A. L., Hunter, Kylie E., Espinoza, D., Mihrshahi, S., Askie, L. M., Askie, Lisa M., on behalf of the EPOCH Collaboration, Espinoza, David, Martin, Andrew, Daniels, Lynne A., Mihrshahi, Seema, Taylor, Rachael, Wen, Li Ming, Campbell, Karen, Hesketh, Kylie D., Rissel, Chris, Taylor, Barry, Magarey, Anthea, Seidler, Anna Lene and Baur, Louise A. (2021). Quantifying the advantages of conducting a prospective meta-analysis (PMA): a case study of early childhood obesity prevention. Trials, 22 (1) 78, 1-8. doi: 10.1186/s13063-020-04984-x
Coskinas, Xanthi, Schou, I. Manjula, Simes, John and Martin, Andrew (2021). Reacting to prognostic covariate imbalance in randomised controlled trials. Contemporary Clinical Trials, 110 106544, 1-7. doi: 10.1016/j.cct.2021.106544
Emmett, Louise, Subramaniam, Shalini, Joshua, Anthony M., Crumbaker, Megan, Martin, Andrew, Zhang, Alison Y., Rana, Nisha, Langford, Ailsa, Mitchell, Jenna, Yip, Sonia, Francis, Roslyn, Hofman, Michael S., Sandhu, Shahneen, Azad, Arun, Gedye, Craig, McJannett, Margaret, Stockler, Martin R. and Davis, Ian D. (2021). ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901). BJU International, 128 (5), 642-651. doi: 10.1111/bju.15491
Mazza, Danielle, Lin, Xiaoping, Walter, Fiona M., Young, Jane M., Barnes, David J., Mitchell, Paul L., Brijnath, Bianca, Martin, Andrew, O'Byrne, Kenneth J. and Emery, Jon D. (2021). Do ethnic patients report longer lung cancer intervals than Anglo-Australian patients?: Findings from a prospective, observational cohort study. European Journal of Cancer Care, 30 (6) e13492, 1-11. doi: 10.1111/ecc.13492
Sweeney, Christopher J., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Reaume, M. Neil, Sandhu, Shahneen K., Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia ... Davis, Ian D. (2021). Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy. European Urology, 80 (3), 275-279. doi: 10.1016/j.eururo.2021.05.016
Hofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Ng, Siobhan, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Redfern, Andrew D., Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Y., McJannett, Margaret M., Stockler, Martin R., Violet, John A. ... TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2021). [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial. The Lancet, 397 (10276), 797-804. doi: 10.1016/S0140-6736(21)00237-3
Blinman, Prunella, Martin, Andrew, Jefford, Michael, Goldstein, David, Boadle, David, Morris, Michelle, Tebbutt, Niall, Aiken, Christine, Harkin, Andrea, Segelov, Eva, Haydon, Andrew, Iveson, Tim and Stockler, Martin R. (2021). Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. JNCI Cancer Spectrum, 5 (1) pkaa107, 1-6. doi: 10.1093/jncics/pkaa107
Trinh, Terry, Park, Susanna B., Murray, Jenna, Pickering, Hannah, Lin, Cindy S.-Y., Martin, Andrew, Friedlander, Michael, Kiernan, Matthew C., Goldstein, David and Krishnan, Arun V. (2021). Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial. Supportive Care in Cancer, 29 (2), 1103-1110. doi: 10.1007/s00520-020-05591-x
Lau, David K., Luk, Ian Y., Jenkins, Laura J., Martin, Andrew, Williams, David S., Schoffer, Kael L., Chionh, Fiona, Buchert, Michael, Sjoquist, Katrin, Boussioutas, Alex, Hayes, Sarah A., Ernst, Matthias, Weickhardt, Andrew J., Pavlakis, Nick, Tebbutt, Niall C. and Mariadason, John M. (2021). Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK. Molecular Cancer Therapeutics, 20 (4), 704-715. doi: 10.1158/1535-7163.MCT-20-0836
Lawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair W. S., Meade, Angela, Goh, Jeffrey, Gurney, Howard, Harrison, Michelle, Fife, Kate, Eisen, Tim, Blinman, Prunella and Stockler, Martin R. (2020). Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma. Kidney Cancer, 4 (4), 185-195. doi: 10.3233/KCA-200104
Vasista, Anuradha, Stockler, Martin R., Martin, Andrew, Lawrence, Nicola J. and Kiely, Belinda E. (2020). Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?. Internal Medicine Journal, 50 (12), 1492-1499. doi: 10.1111/imj.14739
Whitford, Hayley S., Kalinowski, Pawel, Schembri, Adrian, Grimison, Peter, Stockler, Martin, Martin, Andrew, Toner, Guy C., Davis, Ian D., Maruff, Paul and Olver, Ian N. (2020). The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer, 28 (7), 3081-3091. doi: 10.1007/s00520-019-05095-3
Smith-Uffen, M. E.S., Johnson, S. B., Martin, A. J., Tattersall, M. H.N., Stockler, M. R., Bell, M. L., Detering, K., Clayton, J. M., Silvester, W., Clarke, S., Vaccaro, L., Beale, P. and Kiely, B. E. (2020). Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients. Supportive Care in Cancer, 28 (7), 3399-3407. doi: 10.1007/s00520-019-05158-5
Coskinas, Xanthi, Simes, John, Schou, Manjula, Schou, Manjula and Martin, Andrew James (2020). Changes to aspects of ongoing randomised controlled trials with fixed designs. Trials, 21 (1) 457, 1-8. doi: 10.1186/s13063-020-04374-3
Tarnow-Mordi, William O, Abdel-Latif, Mohamed E, Martin, Andrew, Pammi, Mohan, Robledo, Kristy, Manzoni, Paolo, Osborn, David, Lui, Kei, Keech, Anthony, Hague, Wendy, Ghadge, Alpana, Travadi, Javeed, Brown, Rebecca, Darlow, Brian A, Liley, Helen, Pritchard, Margo, Kochar, Anu, Isaacs, David, Gordon, Adrienne, Askie, Lisa, Cruz, Melinda, Schindler, Tim, Dixon, Kerry, Deshpande, Girish, Tracy, Mark, Schofield, Deborah, Austin, Nicola, Sinn, John, Simes, R John ... Espinoza, D. (2020). The effect of lactoferrin supplementation on death or major morbidity in very low birthweight infants (LIFT): a multicentre, double-blind, randomised controlled trial. The Lancet Child and Adolescent Health, 4 (6), 444-454. doi: 10.1016/S2352-4642(20)30093-6
Askie, Lisa M., Espinoza, David, Martin, Andrew, Daniels, Lynne A., Mihrshahi, Seema, Taylor, Rachael, Wen, Li Ming, Campbell, Karen, Hesketh, Kylie D., Rissel, Chris, Taylor, Barry, Magarey, Anthea, Seidler, Anna Lene, Hunter, Kylie E. and Baur, Louise A. (2020). Interventions commenced by early infancy to prevent childhood obesity—The EPOCH Collaboration: An individual participant data prospective meta-analysis of four randomized controlled trials. Pediatric Obesity, 15 (6) e12618, 1-10. doi: 10.1111/ijpo.12618
Moth, Erin B., Kiely, Belinda E., Martin, Andrew, Naganathan, Vasi, Della-Fiorentina, Stephen, Honeyball, Florian, Zielinski, Rob, Steer, Christopher, Mandaliya, Hiren, Ragunathan, Abiramy and Blinman, Prunella (2020). Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences. Journal of Geriatric Oncology, 11 (4), 626-632. doi: 10.1016/j.jgo.2019.07.026
Moth, Erin B., Blinman, Prunella, Stefanic, Natalie, Naganathan, Vasi, Grimison, Peter, Stockler, Martin R., Beale, Philip, Martin, Andrew and Kiely, Belinda E. (2020). Estimating survival time in older adults receiving chemotherapy for advanced cancer. Journal of Geriatric Oncology, 11 (4), 617-625. doi: 10.1016/j.jgo.2019.08.013
Kiran Kumar Balegar, V., Jayawardhana, Madhuka, Martin, Andrew J., de Chazal, Philip and Nanan, Ralph K.H. (2020). Association of Bolus Feeding With Splanchnic and Cerebral Oxygen Utilization Efficiency Among Premature Infants With Anemia and After Blood Transfusion. JAMA Network Open, 3 (2), 1-14. doi: 10.1001/jamanetworkopen.2020.0149
Malesu, Rashi, Martin, Andrew J., Lyons, J. Guy, Scolyer, Richard A., Chen, Andrew C., McKenzie, Catriona A., Madore, Jason, Halliday, Gary M. and Damian, Diona L. (2020). Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma: In vitro and in vivo. Photochemical and Photobiological Sciences, 19 (2), 171-179. doi: 10.1039/c9pp00388f
Asztalos, Elizabeth V., Barrington, Keith, Lodha, Abhay, Tarnow-Mordi, William and Martin, Andrew (2020). Lactoferrin infant feeding trial_Canada (LIFT_Canada): Protocol for a randomized trial of adding lactoferrin to feeds of very-low-birth-weight preterm infants. BMC Pediatrics, 20 (1) 40, 1-8. doi: 10.1186/s12887-020-1938-0
Yee, Jasmine, Davis, Glen M., Hackett, Daniel, Beith, Jane M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2019). Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases. Journal of Pain and Symptom Management, 58 (6), 929-939. doi: 10.1016/j.jpainsymman.2019.07.022
Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876
Vasista, Anuradha, Stockler, Martin, Martin, Andrew, Pavlakis, Nick, Sjoquist, Katrin, Goldstein, David, Gill, Sanjeev, Jain, Vikram, Liu, Geoffrey, Kannourakis, George, Kim, Yeul Hong, Nott, Louise, Snow, Stephanie, Burge, Matthew, Harris, Dean, Jonker, Derek, Chua, Yu Jo, Epstein, Richard, Bonaventura, Antony and Kiely, Belinda (2019). Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer. Oncologist, 24 (11), e1102-e1107. doi: 10.1634/theoncologist.2018-0613
Ow, Lin Li, Subramaniam, Nishamini, Kamisan Atan, Ixora, Friedman, Talia, Martin, Andrew and Dietz, Hans Peter (2019). Should Genital Hiatus/Perineal Body Be Measured at Rest or on Valsalva?. Female Pelvic Medicine and Reconstructive Surgery, 25 (6), 415-418. doi: 10.1097/SPV.0000000000000608
Simes, R. J. and Martin, A. J. (2019). Assumptions, damn assumptions and statistics. Annals of Oncology, 30 (9), 1415-1416. doi: 10.1093/annonc/mdz209
Miu, Michelle W., Martin, Andrew and Cyna, Allan M. (2019). Postoperative pain and comfort scores: Do they correlate?. Anaesthesia and Intensive Care, 47 (5), 435-441. doi: 10.1177/0310057X19861985
Davis, Ian D., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Neil Reaume, M., Sandhu, Shahneen K., Tan, Alvin, Hsiang Tan, T., Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia ... for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (2019). Enzalutamide with standard first-line therapy in metastatic prostate cancer. New England Journal of Medicine, 381 (2), 121-131. doi: 10.1056/NEJMoa1903835
Emery, Jon D., Murray, Sonya R., Walter, Fiona M., Martin, Andrew, Goodall, Stephen, Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Barnes, David John and Murchie, Peter (2019). The Chest Australia Trial: A randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax, 74 (4), 362-370. doi: 10.1136/thoraxjnl-2018-212506
Moth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists’ estimates of toxicity based on clinical judgement. Journal of Geriatric Oncology, 10 (2), 202-209. doi: 10.1016/j.jgo.2018.08.010
Martin, Andrew J., Dhillon, Haryana M., Vardy, Janette L., Dalziell, Robyn A., Choy, Bonita, Fernández-Peñas, Pablo, Dixon, Ann, Renton, Corrinne, St. George, Gayathri, Chinniah, Niranthari, Halliday, Gary M., Damian, Diona L. and Chen, Andrew C. (2019). Neurocognitive function and quality of life outcomes in the ONTRAC study for skin cancer chemoprevention by nicotinamide. Geriatrics, 4 (1) 31, 1-6. doi: 10.3390/geriatrics4010031
Moth, Erin B., Kiely, Belinda E., Stefanic, Natalie, Naganathan, Vasikaran, Martin, Andrew, Grimison, Peter, Stockler, Martin R., Beale, Philip and Blinman, Prunella (2019). Oncologists’ perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer. Journal of Geriatric Oncology, 10 (2), 210-215. doi: 10.1016/j.jgo.2018.11.004
Lee, Kirsty Wai Chung, Lord, Sally, Finn, Richard S., Lim, Elgene, Martin, Andrew, Loi, Sherene, Lynch, Jodi, Friedlander, Michael and Lee, Chee Khoon (2019). The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis. Breast Cancer Research and Treatment, 174 (1), 271-278. doi: 10.1007/s10549-018-5054-x
Minocha, Rashi, Martin, Andrew J., Chen, Andrew C., Scolyer, Richard A., Lyons, J. Guy, McKenzie, Catriona A., Madore, Jason, Halliday, Gary M. and Damian, Diona L. (2019). A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide. Journal of Investigative Dermatology, 139 (2), 467-469. doi: 10.1016/j.jid.2018.08.018
Brakoulias, Vlasios, Starcevic, Vladan, Albert, Umberto, Arumugham, Shyam Sundar, Bailey, Brenda E., Belloch, Amparo, Borda, Tania, Dell'Osso, Liliana, Elias, Jason A., Falkenstein, Martha J., Ferrao, Ygor A., Fontenelle, Leonardo F., Jelinek, Lena, Kalogeraki, Leto, Kay, Brian, Laurito, Luana D., Lochner, Christine, Maina, Giuseppe, Marazziti, Donatella, Martin, Andrew, Matsunaga, Hisato, Miguel, Euripedes C., Morgado, Pedro, Mourikis, Irakis, Pasquini, Massimo, Perez Rivera, Rodrigo, Potluri, Sriramya, Reddy, Janardhan Y.C., Riemann, Brian C. ... Fineberg, Naomi A. (2019). Treatments used for obsessive–compulsive disorder—An international perspective. Human Psychopharmacology, 34 (1) e2686, 1-10. doi: 10.1002/hup.2686
Martin, Andrew, Ghadge, Alpana, Manzoni, Paolo, Lui, Kei, Brown, Rebecca, Tarnow-Mordi, William, Lu, Kei, Simes, John, Hague, Wendy, Osborn, David, Deshpande, Girish, Kochar, Anu, Lewis, Tony, Watkins, Andrew, Pritchard, Margo, Schofield, Deborah, Mohamed, Abdel Latif, Soll, Roger, Darlow, Brian, Isaacs, David, Wilkinson, Dominic, Wood, Alicia, McKenzie, Anne, Despande, Girish, Verry, Hannah, Wright, Ian, Askie, Lisa, Cruz, Melinda, Berry, Nina ... Espinoza, David (2018). Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge. BMJ Open, 8 (10) e023044. doi: 10.1136/bmjopen-2018-023044
Lawrence, Nicola Jane, Roncolato, Felicia, Martin, Andrew, Simes, Robert John and Stockler, Martin R. (2018). Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer. JNCI Cancer Spectrum, 2 (4) pky037, 1-7. doi: 10.1093/JNCICS/PKY037
Lawrence, Nicola J., Chan, Howard, Toner, Guy, Stockler, Martin R., Martin, Andrew, Yip, Sonia, Wong, Nicole, Yeung, Annie, Mazhar, Danish, Pashankar, Farzana, Frazier, Lindsay, McDermott, Ray, Walker, Roderick, Tan, Hsiang, Davis, Ian D. and Grimison, Peter (2018). Protocol for the P3BEP trial (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours. BMC Cancer, 18 (1) 854, 1-6. doi: 10.1186/s12885-018-4745-3
Mazza, Danielle, Lin, Xiaoping, Walter, Fiona M., Young, Jane M., Barnes, David J., Mitchell, Paul, Brijnath, Bianca, Martin, Andrew and Emery, Jon D. (2018). The LEAD study protocol: A mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds. BMC Cancer, 18 (1) 754, 1-8. doi: 10.1186/s12885-018-4671-4
Cheng, Jian Y., Martin, Andrew, Ramanathan, Ganesh and Cooper, Bruce A. (2018). Optimizing live kidney donor workup: A decision analysis approach. Transplantation Direct, 4 (5) e340. doi: 10.1097/TXD.0000000000000777
Martin, Andrew J., Gibbs, Emma, Sjoquist, Katrin, Pavlakis, Nick, Simes, John, Price, Tim, Shannon, Jenny, Gill, Sanjeev, Jain, Vikram, Liu, Geoffrey, Kannourakis, George, Kim, Yeul Hong, Kim, Jin Won and Goldstein, David (2018). Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. Gastric Cancer, 21 (3), 473-480. doi: 10.1007/s10120-017-0754-1
Benzie, R. J., Starcevic, V., Viswasam, K., Kennedy, N. J., Mein, B. J., Wye, D. A. and Martin, A. (2018). Effect of three- vs four-dimensional ultrasonography on maternal attachment. Ultrasound in Obstetrics and Gynecology, 51 (4), 558-559. doi: 10.1002/uog.17567
Moth, E. B., Kiely, B. E., Naganathan, V., Martin, A. and Blinman, P. (2018). How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists. Supportive Care in Cancer, 26 (2), 451-460. doi: 10.1007/s00520-017-3843-0
Blinman, P. L., Davis, I. D., Martin, A., Troon, S., Sengupta, S., Hovey, E., Coskinas, X., Kaplan, R., Ritchie, A., Meade, A., Eisen, T. and Stockler, M. R. (2018). Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: What makes it worthwhile?. Annals of Oncology, 29 (2), 370-376. doi: 10.1093/annonc/mdx715
Lawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair, Meade, Angela, Eisen, Tim, Blinman, Prunella and Stockler, Martin R. (2018). What survival benefits are needed to make adjuvant sorafenib worthwhile after resection of intermediate- or high-risk renal cell carcinoma? Clinical investigators' preferences in the SORCE trial. Kidney Cancer, 2 (2), 123-131. doi: 10.3233/KCA-180038
Jefford, Michael, Emery, Jon, Grunfeld, Eva, Martin, Andrew, Rodger, Paula, Murray, Alexandra M., De Abreu Lourenco, Richard, Heriot, Alexander, Phipps-Nelson, Jo, Guccione, Lisa, King, Dorothy, Lisy, Karolina, Tebbutt, Niall, Burgess, Adele, Faragher, Ian, Woods, Rodney and Schofield, Penelope (2017). SCORE: Shared care of Colorectal cancer survivors: Protocol for a randomised controlled trial. Trials, 18 (1) 506, 1-10. doi: 10.1186/s13063-017-2245-4
Ferreira, Caroline W. S., Atan, Ixora K., Martin, Andrew, Shek, Ka Lai and Dietz, Hans Peter (2017). Pelvic organ support several years after a first birth. International Urogynecology Journal, 28 (10), 1499-1505. doi: 10.1007/s00192-017-3297-4
Dobler, Claudia C., Cheung, Kelvin, Nguyen, John and Martin, Andrew (2017). Risk of tuberculosis in patients with solid cancers and haematological malignancies: A systematic review and meta-analysis. European Respiratory Journal, 50 (2) 1700157, 1700157. doi: 10.1183/13993003.00157-2017
Kumar, N. T. Uday and Martin, Andrew (2017). Experimental modeling of an air-gap membrane distillation module and simulation of a solar thermal integrated system for water purification. Desalination and Water Treatment, 84, 123-134. doi: 10.5004/dwt.2017.21201
Karikios, Deme John, Mileshkin, Linda, Martin, Andrew, Ferraro, Danielle and Stockler, Martin R. (2017). Discussing and prescribing expensive unfunded anticancer drugs in Australia. ESMO Open, 2 (2) e000170. doi: 10.1136/esmoopen-2017-000170
Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Lawrence, Nicola, Martin, Andrew, Sengupta, Shomik and Davis, Ian D. (2017). BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. BJU International, 119 (S5), 55-57. doi: 10.1111/bju.13873
Caudwell-Hall, Jessica, Kamisan Atan, Ixora, Martin, Andrew, Guzman Rojas, Rodrigo, Langer, Susanne, Shek, Kalai and Dietz, Hans P. (2017). Intrapartum predictors of maternal levator ani injury. Acta Obstetricia et Gynecologica Scandinavica, 96 (4), 426-431. doi: 10.1111/aogs.13103
Karikios, Deme J., Chim, Lesley, Martin, Andrew, Nagrial, Adnan, Howard, Kirsten, Salkeld, Glenn and Stockler, Martin R. (2017). Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia. Internal Medicine Journal, 47 (4), 400-407. doi: 10.1111/imj.13350
Tattersall, Martin H N, Jefford, Michael, Martin, Andrew, Olver, Ian, Thompson, John F, Brown, Richard F and Butow, Phyllis N (2017). Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials. BMJ Open, 7 (3) e012666. doi: 10.1136/bmjopen-2016-012666
Emery, Jon D., Jefford, Michael, King, Madeleine, Hayne, Dickon, Martin, Andrew, Doorey, Juanita, Hyatt, Amelia, Habgood, Emily, Lim, Tee, Hawks, Cynthia, Pirotta, Marie, Trevena, Lyndal and Schofield, Penelope (2017). ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU International, 119 (3), 381-389. doi: 10.1111/bju.13593
Woldemariam, Daniel, Martin, Andrew and Santarelli, Massimo (2017). Exergy Analysis of Air-Gap Membrane Distillation Systems for Water Purification Applications. Applied Sciences-Basel, 7 (3) ARTN 301, 301. doi: 10.3390/app7030301
Samavati, Mahrokh, Santarelli, Massimo, Martin, Andrew and Nemanova, Vera (2017). Thermodynamic and economy analysis of solid oxide electrolyser system for syngas production. Energy, 122, 37-49. doi: 10.1016/j.energy.2017.01.067
Damian, D. L., Martin, A. J., Scolyer, R. A., Chen, A. C. and Halliday, G. M. (2017). Authors' response to a reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’. British Journal of Dermatology, 176 (2), 552-553. doi: 10.1111/bjd.15204
Chan, David L., Sjoquist, Katrin M., Goldstein, David, Price, Timothy J., Martin, Andrew J., Bang, Yung-Jue, Kang, Yoon-Koo and Pavlakis, Nick (2017). The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis. PLoS ONE, 12 (2) e0172307, e0172307. doi: 10.1371/journal.pone.0172307
Kabalina, Natalia, Costa, Mario, Yang, Weihong, Martin, Andrew and Santarelli, Massimo (2017). Exergy analysis of a polygeneration-enabled district heating and cooling system based on gasification of refuse derived fuel. Journal of Cleaner Production, 141, 760-773. doi: 10.1016/j.jclepro.2016.09.151
Pickering, Hannah, Murray, Jenna, Lin, Cindy S.-Y., Cormack, Christine, Martin, Andrew, Kiernan, Matthew C. and Krishnan, Arun V. (2017). Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trial. Clinical Neurophysiology, 128 (1), 93-99. doi: 10.1016/j.clinph.2016.10.088
Woldemariam, Daniel, Kullab, Alaa, Fortkamp, Uwe, Magner, Jorgen, Royen, Hugo and Martin, Andrew (2016). Membrane distillation pilot plant trials with pharmaceutical residues and energy demand analysis. Chemical Engineering Journal, 306, 471-483. doi: 10.1016/j.cej.2016.07.082
Trutnovsky, Gerda, Kamisan Atan, Ixora, Ulrich, Daniela, Martin, Andrew and Dietz, Hans P. (2016). Levator ani trauma and pelvic organ prolapse – a comparison of three translabial ultrasound scoring systems. Acta Obstetricia et Gynecologica Scandinavica, 95 (12), 1411-1417. doi: 10.1111/aogs.13018
Lawrence, N., Martin, A., Toner, G., Stockler, M., Buizen, L., Thomson, D., Gebski, V., Friedlander, M., Yeung, A., Wong, N., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S., Lewis, C., Vasey, P. and Grimison, P. (2016). Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of Oncology, 27 (12), 2302-2303. doi: 10.1093/annonc/mdw313
Chen, A. C., Martin, A. J., Dalziell, R. A., Halliday, G. M. and Damian, D. L. (2016). Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial. British Journal of Dermatology, 175 (6), 1363-1365. doi: 10.1111/bjd.14648
Birru, Eyerusalem, Erlich, Catharina, Herrera, Idalberto, Martin, Andrew, Feychting, Sofia, Vitez, Marina, Abdulhadi, Emma Bednarcik, Larsson, Anna, Onoszko, Emanuel, Hallersbo, Mattias, Weilenmann, Louise and Puskoriute, Laura (2016). A Comparison of Various Technological Options for Improving Energy and Water Use Efficiency in a Traditional Sugar Mill. Sustainability, 8 (12) ARTN 1227, 1227. doi: 10.3390/su8121227
Kabalina, Natalia, Costa, Mario, Yang, Weihong and Martin, Andrew (2016). Production of Synthetic Natural Gas from Refuse-Derived Fuel Gasification for Use in a Polygeneration District Heating and Cooling System. Energies, 9 (12) ARTN 1080, 1080. doi: 10.3390/en9121080
Ling, Nicholas and Martin, Andrew (2016). Three suturing techniques for closing fusiform excisions. A randomised controlled study. Australasian Journal of Dermatology, 57 (4), 271-277. doi: 10.1111/ajd.12359
Wye, D., Woo, J., Mein, B., Magotti, R., Martin, A. and Benzie, R. (2016). Transperineal use of a pocket-sized ultrasound machine vs conventional transvaginal ultrasound: a blinded comparison of cervical length in pregnancy. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 48 (4), 535-536. doi: 10.1002/uog.15861
Pavlakis, Nick, Sjoquist, Katrin M., Martin, Andrew J., Tsobanis, Eric, Yip, Sonia, Kang, Yoon-Koo, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Burnell, Margot J., Tebbutt, Niall C., Rha, Sun Young, Lee, Jeeyun, Cho, Jae-Yong, Lipton, Lara R., Wong, Mark, Strickland, Andrew, Kim, Jin Won, Zalcberg, John R., Simes, John and Goldstein, David (2016). Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial. Journal of Clinical Oncology, 34 (23), 2728-2735. doi: 10.1200/JCO.2015.65.1901
Trutnovsky, G., Kamisan Atan, I., Martin, A. and Dietz, H. P. (2016). Delivery mode and pelvic organ prolapse: a retrospective observational study. BJOG: An International Journal of Obstetrics and Gynaecology, 123 (9), 1551-1556. doi: 10.1111/1471-0528.13692
Brakoulias, Vlasios, Starcevic, Vladan, Belloch, Amparo, Dell’Osso, Liliana, Fer rão, Ygor A., Fontenelle, Leonardo F., Lochner, Christine, Marazziti, Donatella, Martin, Andrew, Matsunaga, Hisato, Miguel, Euripedes C., Reddy, Y. C. Janardhan, do Rosário, Maria C., Shavitt, Roseli G., Sundar, Arumugham Shyam, Stein, Dan Joseph and Viswasam, Kirupamani (2016). International prescribing practices in obsessive–compulsive disorder (OCD). Human Psychopharmacology, 31 (4), 319-324. doi: 10.1002/hup.2541
Naranjo-Ortiz, Cristina, Shek, Ka Lai, Martin, Andrew James and Dietz, Hans Peter (2016). What is normal bladder neck anatomy?. International Urogynecology Journal, 27 (6), 945-950. doi: 10.1007/s00192-015-2916-1
Birru, Eyerusalem, Erlich, Catharina, Beyene, Getachew Bekele and Martin, Andrew (2016). Assessing the potential of energy saving in a traditional sugar cane mill during steady state and transient conditions-part I: base case plant model. Biomass Conversion and Biorefinery, 6 (2), 219-232. doi: 10.1007/s13399-015-0179-1
Mohan, Gowtham, Kumar, N. T. Uday, Pokhrel, Manoj Kumar and Martin, Andrew (2016). Experimental investigation of a novel solar thermal polygeneration plant in United Arab Emirates. Renewable Energy, 91, 361-373. doi: 10.1016/j.renene.2016.01.072
Birru, Eyerusalem, Erlich, Catharina, Beyene, Getachew Bekele and Martin, Andrew (2016). Upgrading of a traditional sugar cane mill to a modern mill and assessing the potential of energy saving during steady state and transient conditions-part II: models for a modified cogeneration unit. Biomass Conversion and Biorefinery, 6 (2), 233-245. doi: 10.1007/s13399-015-0180-8
Brakoulias, Vlasios, Starcevic, Vladan, Martin, Andrew, Berle, David, Milicevic, Denise and Viswasam, Kirupamani (2016). The familiality of specific symptoms of obsessive-compulsive disorder. Psychiatry Research, 239, 315-319. doi: 10.1016/j.psychres.2016.03.047
Kumar, N. T. Uday, Mohan, Gowtham and Martin, Andrew (2016). Performance analysis of solar cogeneration system with different integration strategies for potable water and domestic hot water production. Applied Energy, 170, 466-475. doi: 10.1016/j.apenergy.2016.02.033
Dobler, Claudia C., Martin, Andrew and Marks, Guy B. (2016). Benefit of treatment of latent tuberculosis infection in individual patients. The European respiratory journal, 47 (5), 1594-1595. doi: 10.1183/13993003.00175-2016
Jackson, M. J., Patvardhan, C., Wallace, F., Martin, A., Yusuff, H., Briggs, G. and Malik, R. A. (2016). Perioperative management of diabetes in elective patients: A region-wide audit. British Journal of Anaesthesia, 116 (4), 501-506. doi: 10.1093/bja/aev554
Mohan, Gowtham, Kumar, Uday, Pokhrel, Manoj Kumar and Martin, Andrew (2016). A novel solar thermal polygeneration system for sustainable production of cooling, clean water and domestic hot water in United Arab Emirates: Dynamic simulation and economic evaluation. Applied Energy, 167, 173-188. doi: 10.1016/j.apenergy.2015.10.116
Chen, Andrew C., Martin, Andrew J. and Damian, Diona L. (2016). The authors reply. New England Journal of Medicine, 374 (8). doi: 10.1056/NEJMc1514791
Hong, Angela, Zhang, Xiaoying, Jones, Deanna, Veillard, Anne-Sophie, Zhang, Mei, Martin, Andrew, Lyons, J. Guy, Lee, C. Soon and Rose, Barbara (2016). Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma. Radiotherapy and Oncology, 118 (2), 342-349. doi: 10.1016/j.radonc.2016.02.009
Duchesne, Gillian M., Haworth, Annette, Bone, Eric, Carter, Hannah, Ebert, Martin A., Gagliardi, Frank, Gibbs, Adrian, Hornby, Colin, Martin, Andrew, Sidhom, Mark, Wood, Maree and Jackson, Michael (2016). Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology, 60 (1), 129-137. doi: 10.1111/1754-9485.12390
Chen, A. C., Martin, A. J., Dalziell, R. A., McKenzie, C. A., Lowe, P. M., Eris, J. M., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Bielski, V. A., Halliday, G. M. and Damian, D. L. (2016). A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology, 175 (5), 1073-1075. doi: 10.1111/bjd.14662
Kennedy, N. J., Peek, M. J., Quinton, A. E., Lanzarone, V., Martin, A., Benzie, R. and Nanan, R. (2016). Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: A longitudinal cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 123 (2), 225-232. doi: 10.1111/1471-0528.13758
Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Chalasani, Venu, Long, Anne, Martin, Andrew, Sengupta, Shomik and Davis, Ian D. (2015). BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301). BMC Cancer, 15 (1) 432. doi: 10.1186/s12885-015-1431-6
Dobler, Claudia C., Martin, Andrew and Marks, Guy B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46 (5), 1397-1406. doi: 10.1183/13993003.00577-2015
Chen, Andrew C., Martin, Andrew J., Choy, Bonita, Fernandez-Penas, Pablo, Dalziell, Robyn A., McKenzie, Catriona A., Scolyer, Richard A., Dhillon, Haryana M., Vardy, Janette L., Kricker, Anne, George, Gayathri St., Chinniah, Niranthari, Halliday, Gary M. and Damian, Diona L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373 (17), 1618-1626. doi: 10.1056/NEJMoa1506197
Duchesne, Gillian M., Grand, Mel, Kron, Tomas, Haworth, Annette, Corry, June, Jackson, Michael, Ng, Michael, Besuijen, Deidre, Carter, Hannah E., Martin, Andrew, Schofield, Deborah, Gebski, Val, Torony, Joan, Kovacev, Olga, Amin, Rowena and Burmeister, Bryan (2015). Trans Tasman Radiation Oncology Group: development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology, 59 (3), 363-370. doi: 10.1111/1754-9485.12255
Davis, Ian D., Long, A., Yip, S., Espinoza, D., Thompson, J. F., Kichenadasse, G., Harrison, M., Lowenthal, R. M., Pavlakis, N., Azad, A., Kannourakis, G., Steer, C., Goldstein, D., Shapiro, J., Harvie, R., Jovanovic, L., Hudson, A. L., Nelson, C. C., Stockler, M. R. and Martin, A. (2015). EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. Annals of Oncology, 26 (6), 1118-1123. doi: 10.1093/annonc/mdv078
Murray, Sonya R., Murchie, Peter, Campbell, Neil, Walter, Fiona M., Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Martin, Andrew, Goodall, Stephen, Barnes, David J. and Emery, Jon D (2015). Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer. BMJ Open, 5 (5) e008046, 1-7. doi: 10.1136/bmjopen-2015-008046
Yee, Jasmine, Davis, Glen M., Beith, Jane M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2014). Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship, 8 (4), 647-656. doi: 10.1007/s11764-014-0378-y
Thibault-Gagnon, Stéphanie, Yusuf, Sara, Langer, Suzanne, Wong, Vivien, Shek, Ka Lai, Martin, Andrew and Dietz, Hans Peter (2014). Do women notice the impact of childbirth-related levator trauma on pelvic floor and sexual function? Results of an observational ultrasound study. International Urogynecology Journal, 25 (10), 1389-1398. doi: 10.1007/s00192-014-2331-z
Carter, Hannah E., Martin, Andrew, Schofield, Deborah, Duchesne, Gillian, Haworth, Annette, Hornby, Colin, Sidhom, Mark and Jackson, Michael (2014). A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology, 112 (2), 187-193. doi: 10.1016/j.radonc.2014.03.020
Wong, Vivien, Shek, Ka Lai, Goh, Judith, Krause, Hannah, Martin, Andrew and Dietz, Hans Peter (2014). Cystocele recurrence after anterior colporrhaphy with and without mesh use. European Journal of Obstetrics and Gynecology and Reproductive Biology, 172 (1), 131-135. doi: 10.1016/j.ejogrb.2013.11.001
Phu, Amy L., Xu, Zheyu, Brakoulias, Vlasios, Mahant, Neil, Fung, Victor S.C., Moore, Gregory De, Martin, Andrew, Starcevic, Vladan and Krause, Martin (2014). Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. Journal of Clinical Neuroscience, 21 (1), 63-66. doi: 10.1016/j.jocn.2013.02.032
Brakoulias, Vlasios, Starcevic, Vladan, Berle, David, Milicevic, Denise, Hannan, Anthony and Martin, Andrew (2014). The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder. Psychiatric Quarterly, 85 (2), 133-142. doi: 10.1007/s11126-013-9278-y
Emery, Jon, Doorey, Juanita, Jefford, Michael, King, Madeleine, Pirotta, Marie, Hayne, Dickon, Martin, Andrew, Trevena, Lyndal, Lim, Tee, Constable, Roger, Hawks, Cynthia, Hyatt, Amelia, Hamid, Akhlil, Violet, John, Gill, Suki, Frydenberg, Mark and Schofield, Penelope (2014). Protocol for the ProCare Trial: A phase II randomised controlled trial of shared care for follow-up of men with prostate cancer. BMJ Open, 4 (3) e004972, 1-10. doi: 10.1136/bmjopen-2014-004972
Martin, Andrew J., Darlow, Brian A., Salt, Alison, Hague, Wendy, Sebastian, Lucille, McNeill, Nicki and Tarnow-Mordi, William (2013). Performance of the Parent Report of Children's Abilities-Revised (PARCA-R) versus the Bayley Scales of Infant Development III. Archives of Disease in Childhood, 98 (12), 955-958. doi: 10.1136/archdischild-2012-303288
Kiely, Belinda E., Martin, Andrew J., Tattersall, Martin H. N., Nowak, Anna K., Goldstein, David, Wilcken, Nicholas R. C., Wyld, David K., Abdi, Ehtesham A., Glasgow, Amanda, Beale, Philip J., Jefford, Michael, Glare, Paul A. and Stockler, Martin R. (2013). The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates. Journal of Clinical Oncology, 31 (28), 3565-3572. doi: 10.1200/JCO.2012.44.7821
Ghosh, Justin, Martin, Andrew, Keech, Anthony C., Chan, Kim H., Gomes, Sean, Singarayar, Suresh and McGuire, Mark A. (2013). Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm, 10 (9), 1311-1317. doi: 10.1016/j.hrthm.2013.06.014
Dietz, H. P., Nazemian, K., Shek, K. L. and Martin, A. (2013). Can urodynamic stress incontinence be diagnosed by ultrasound?. International Urogynecology Journal and Pelvic Floor Dysfunction, 24 (8), 1399-1403. doi: 10.1007/s00192-012-2032-4
Hong, Angela M., Martin, Andrew, Chatfield, Mark, Jones, Deanna, Zhang, Mei, Armstrong, Bruce, Lee, C. Soon, Harnett, Gerald, Milross, Christopher, Clark, Jonathan, Elliott, Michael, Smee, Robert, Corry, June, Liu, Chen, Porceddu, Sandro, Rees, Guy and Rose, Barbara (2013). Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer, 132 (12), 2748-2754. doi: 10.1002/ijc.27956
Liu, Anthony, Carlsson, Eva, Nilsson, Sofia, Oei, Julee, Bajuk, Barbara, Peek, Michael, Martin, Andrew and Nanan, Ralph (2013). Hypertensive disease of pregnancy is associated with decreased risk for respiratory distress syndrome in moderate preterm neonates. Hypertension in Pregnancy, 32 (2), 169-177. doi: 10.3109/10641955.2013.784786
Martin, Andrew J., Lord, Sarah J., Verry, Hannah E., Stockler, Martin R. and Emery, Jon D. (2013). Risk assessment to guide prostate cancer screening decisions: A cost-effectiveness analysis. Medical Journal of Australia, 198 (10), 546-550. doi: 10.5694/mja12.11597
Hong, A. M., Martin, A., Armstrong, B. K., Lee, C. S., Jones, D., Chatfield, M. D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G. and Rose, B. (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24 (1) mds205, 215-219. doi: 10.1093/annonc/mds205
Brakoulias, Vlasios, Starcevic, Vladan, Berle, David, Milicevic, Denise, Moses, Karen, Hannan, Anthony, Sammut, Peter and Martin, Andrew (2013). The characteristics of unacceptable/taboo thoughts in obsessive-compulsive disorder. Comprehensive Psychiatry, 54 (7), 750-757. doi: 10.1016/j.comppsych.2013.02.005
Brakoulias, Vlasios, Starcevic, Vladan, Berle, David, Sammut, Peter, Milicevic, Denise, Moses, Karen, Hannan, Anthony and Martin, Andrew (2013). Further support for five dimensions of obsessive-compulsive symptoms. Journal of Nervous and Mental Disease, 201 (6), 452-459. doi: 10.1097/NMD.0b013e318294804e
Trutnovsky, Gerda, Guzman-Rojas, Rodrigo, Martin, Andrew and Dietz, Hans P. (2013). Pelvic floor dysfunction-Does menopause duration matter?. Maturitas, 76 (2), 134-138. doi: 10.1016/j.maturitas.2013.06.012
Brakoulias, Vlasios, Starcevic, Vladan, Berle, David, Milicevic, Denise, Moses, Karen, Hannan, Anthony, Sammut, Peter and Martin, Andrew (2013). The use of psychotropic agents for the symptoms of obsessive-compulsive disorder. Australasian Psychiatry, 21 (2), 117-121. doi: 10.1177/1039856212470502
Blinkhorn, Fiona, Brown, Ngiare, Freeman, Ruth, Humphris, Gerry, Martin, Andrew and Blinkhorn, Anthony (2012). A phase II clinical trial of a dental health education program delivered by aboriginal health workers to prevent early childhood caries. BMC Public Health, 12 (1) 681. doi: 10.1186/1471-2458-12-681
Dietz, H. P., Velez, D., Shek, K. L. and Martin, A. (2012). Determination of postvoid residual by translabial ultrasound. International Urogynecology Journal and Pelvic Floor Dysfunction, 23 (12), 1749-1752. doi: 10.1007/s00192-012-1769-0
Suresh, Ashwin, Liu, Anthony, Poulton, Alison, Quinton, Ann, Amer, Zara, Mongelli, Max, Martin, Andrew, Benzie, Ronald, Peek, Michael and Nanan, Ralph (2012). Comparison of maternal abdominal subcutaneous fat thickness and body mass index as markers for pregnancy outcomes: A stratified cohort study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52 (5), 420-426. doi: 10.1111/j.1479-828X.2012.01471.x
Eviston, David P., Quinton, Ann E., Benzie, Ron J., Peek, Michael J., Martin, Andrew and Nanan, Ralph K. (2012). Impaired fetal thymic growth precedes clinical preeclampsia: A case-control study. Journal of Reproductive Immunology, 94 (2), 183-189. doi: 10.1016/j.jri.2012.04.001
Verry, H., Lord, S. J., Martin, A., Gill, G., Lee, C. K., Howard, K., Wetzig, N. and Simes, J. (2012). Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: A decision model analysis. British Journal of Cancer, 106 (6), 1045-1052. doi: 10.1038/bjc.2012.62
Martin, Andrew J., Darlow, Brian A., Salt, Alison, Hague, Wendy, Sebastian, Lucille, Mann, Kristy and Tarnow-Mordi, William (2012). Identification of infants with major cognitive delay using parental report. Developmental Medicine and Child Neurology, 54 (3), 254-259. doi: 10.1111/j.1469-8749.2011.04161.x
Surjana, Devita, Halliday, Gary M., Martin, Andrew J., Moloney, Fergal J. and Damian, Diona L. (2012). Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. Journal of Investigative Dermatology, 132 (5), 1497-1500. doi: 10.1038/jid.2011.459
Kim, Jong S., Bashford, Guy, Murphy, T. Kevin, Martin, Andrew, Dror, Vardit and Cheung, Raymond (2011). Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain, 152 (5), 1018-1023. doi: 10.1016/j.pain.2010.12.023
Guan, Yuzhou, Ding, Xinsheng, Cheng, Yan, Fan, Dongsheng, Tan, Lan, Wang, Yongjun, Zhao, Zhongxin, Hong, Zhen, Zhou, Dong, Pan, Xiaoping, Chen, Shengdi, Martin, Andrew, Tang, Haiyun and Cui, Liying (2011). Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China. Clinical Therapeutics, 33 (2), 159-166. doi: 10.1016/j.clinthera.2011.02.007
Chen, Chunqing, Dong, Jin Song, Sun, Jun and Martin, Andrew (2010). A Verification System for Interval-Based Specification Languages. Acm Transactions On Software Engineering and Methodology, 19 (4) ARTN 13. doi: 10.1145/1734229.1734232
Sir, Aytekin, D'Souza, Russell F., Uguz, Sukru, George, Tom, Vahip, Simavi, Hopwood, Malcolm, Martin, Andrew J., Lam, William and Burt, Tal (2005). Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms. Journal of Clinical Psychiatry, 66 (10), 1312-1320. doi: 10.4088/JCP.v66n1015
Rischin, Danny, Phillips, Kelly-Anne, Friedlander, Michael, Harnett, Paul, Quinn, Michael, Richardson, Gary and Martin, Andrew (2004). A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer. Gynecologic Oncology, 93 (2), 417-421. doi: 10.1016/j.ygyno.2004.01.037
Eckermann, Simon D., Martin, Andrew J., Stockler, Martin R. and Simes, R. John (2003). The benefits and costs of tamoxifen for breast cancer prevention. Australian and New Zealand Journal of Public Health, 27 (1), 34-40. doi: 10.1111/j.1467-842X.2003.tb00377.x
Glasziou, P. P., Eckermann, S. D., Mulray, S. E., Simes, R. J., Martin, A. J., Kirby, A. C., Hall, J. P., Caleo, S., White, H. D. and Tonkin, A. M. (2002). Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?. Medical Journal of Australia, 177 (8), 428-434. doi: 10.5694/j.1326-5377.2002.tb04883.x
Martin, A., Glasziou, P. P., Simes, R. J. and Lumley, T. (2000). A comparison of standard gamble, time trade-off and adjusted time trade-off scores. International Journal of Technology Assessment in Health, 16 (1), 137-147. doi: 10.1017/S0266462300161124
Malik, R., Martin, P., McGill, J., Martin, A. and Love, D. N. (2000). Successful treatment of invasive nasal cryptococcosis in a ferret. Australian Veterinary Journal, 78 (3), 158-159. doi: 10.1111/j.1751-0813.2000.tb10582.x
Martin, A. (1999). Quality of life assessment, evidence-based medicine and cancer prevention. Cancer Forum, 23 (3), 142-143.
Martin, A. J., Glasziou, P. P. and Simes, R. J. (1999). A cardiovascular extension of the Health Measurement Questionnaire. Journal of Epidemiology and Community Health, 53 (9), 548-557. doi: 10.1136/jech.53.9.548
Martin, A. J., Glasziou, P. P., Simes, R. J. and Lumley, T. (1998). Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H. Quality of Life Research, 7 (8), 703-711. doi: 10.1023/A:1008857131564
Tonkin, A., Aylward, P., Colquhoun, D., Glasziou, P., Harris, P., MacMahon, S., Magnus, P., Newel, D., Nestel, P., Sharpe, N., Hunt, D., Shaw, J., Simes, R. J., Thompson, P., Thomson, A., West, M., White, H., Simes, S., Hague, W., Caleo, S., Hall, J., Martin, A., Mulray, S., Barter, P., Beilin, L., Collins, R., McNeil, J., Meier, P., Willimott, H. ... Keech, A. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine, 339 (19), 1349-1357. doi: 10.1056/NEJM199811053391902
Martin, Andrew J. and Stockler, Martin (1998). Quality-of-life assessment in health care research and practice. Evaluation and the Health Professions, 21 (2), 141-156. doi: 10.1177/016327879802100202
Tonkin, A., Aylward, P., Colquhoun, D., Glasziou, P., Harris, P., Hunt, D., MacMahon, S., Nestel, P., Sharpe, N., Símes, J., Thompson, P., Thomson, A., West, M., White, H., Shaw, J., Ablett, M., MacAskill, M., Turner, R., Magnus, P., Wallace, P., Keech, A., Newell, D., Raupach, H., Hague, W., Hall, J., Mulray, S., Wiseman, V., Davies, P., Smithers, D. ... Thompson, R. (1995). Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris. The American Journal of Cardiology, 76 (7), 474-479. doi: 10.1016/S0002-9149(99)80133-7
Oldenburg, B., Martin, A., Greenwood, J., Bernstein, L. and Allan, R. (1995). A controlled trial of a behavioral and educational intervention following coronary artery bypass surgery. Journal of Cardiopulmonary Rehabilitation, 15 (1), 39-46. doi: 10.1097/00008483-199501000-00006
Duque‐Portugal, Francisco, Martin, Andrew J., Taylor, Richard and Ross, Michael W. (1994). Mark‐recapture estimates of injecting drug users in Sydney. Australian Journal of Public Health, 18 (2), 201-204. doi: 10.1111/j.1753-6405.1994.tb00226.x
Benoit, G., Alexandre, L., Bensadoun, H., Vieillefond, A., Martin, P. R., Martin, A. and Jardin, A. (1991). Preservation of the bladder in transitional cell cancer infiltrating the lamina propria PRESERVATION DE LA VESSIE DANS LES TUMEURS PARAMALPIGHIENNES INFILTRANT LE CHORION. Presse Medicale, 20 (30), 1425-1428.
Conference Papers
Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551
Horvath, L.G., Lin, H-M., Davis, I.D., Martin, A., Scheinberg, T., Meikle, P., Joshua, A., Mcjannett, M., Subhash, V., Yip, S., North, S., McDermott, R.S., Chi, K.N., Stockler, M.R. and Sweeney, C. (2024). Association of the lipid biomarker, PCPro, and clinical outcomes in the ENZAMET trial (ANZUP 1304). ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.1688
Hamid, A.A., Thomas, H., Martin, A., Soon, Y.Y., Horvath, L.G., Zielinski, R., Thomson, A., Tan, H., Sandhu, S.K., Reaume, M.N., Pook, D.W., Parnis, F., McDermott, R.S., Lawrence, N., Frydenberg, M., Chi, K.N., Stockler, M.R., Davis, I.D. and Sweeney, C. (2024). Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304). ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.1699
Kwan, Edmond Michael, Hofman, Michael S., Ng, Sarah W. S., Emmett, Louise, Sandhu, Shahneen, Buteau, James Patrick, Iravani, Amir, Joshua, Anthony M., Francis, Roslyn J., Subhash, Vinod, Lee, Sze Ting, Scott, Andrew Mark, Martin, Andrew James, Stockler, Martin R., Donnellan, Gráinne, Annala, Matti, Tolmeijer, Sofie H., Azad, Arun, Davis, Ian D., Wyatt, Alexander William and TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2024). Circulating tumour DNA fraction as a predictor of treatment efficacy in a randomized phase 2 trial of [177Lu]Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel (TheraP ANZUP 1603). 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May-4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.5055
Gedye, C., Harris, C. A., Stockler, M. R., Morris, M., Ferguson, T., Goh, J. C. H., Martin, A., Underhill, C. R., Pook, D., Krieger, L. E. M., Kichenadasse, G., Joshi, A. J., Subramaniam, S., Zebic, D. S., Zhang, A., Joshua, A. M., Toner, G. C., Vasey, P. A., Prithviraj, P. and Davis, I. D. (2023). Pembrolizumab and denosumab in clear cell renal cell carcinoma (ccRCC): A phase II trial (KeyPAD, ANZUP1601). Congress of the European-Society-for-Medical-Oncology (ESMO), Madrid Spain, Oct 20-24, 2023. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2023.09.1116
Horvath, L. G., Davis, I. D., Martin, A., Zielinski, R., Thomson, A., Tan, T. H., Sandhu, S. K., Reaume, M. N., Pook, D., Parnis, F., North, S., Marx, G. M., McCaffrey, J. A., McDermott, R. S., Lawrence, N., Frydenberg, M., Chowdhury, S., Chi, K. N. N., Stockler, M. R. and Sweeney, C. (2023). Effects of enzalutamide on overall survival plus /- early docetaxel in participants aged less than 70 yrs versus greater than or equal to 70 yrs in ENZAMET (ANZUP 1304). Congress of the European-Society-for-Medical-Oncology (ESMO), Madrid Spain, Oct 20-24, 2023. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2023.09.2742
Emmett, L., Subramaniam, S., Crumbaker, M., Joshua, A. M., Weickhardt, A. J., Lee, S. T., Ng, S., Francis, R. J., Goh, J. C. H., Pattison, D. A., Tan, H., Kirkwood, I. D., Sandhu, S. K., Nguyen, A., Gedye, C., Rutherford, N., Hofman, M., Martin, A., Stockler, M. R. and Davis, I. D. (2023). Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901). Congress of the European-Society-for-Medical-Oncology (ESMO), Madrid Spain, Oct 20-24, 2023. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2023.10.086
Zebic, Danka Sinikovic, Ben Tran,, Martin, Andrew James, Pashankar, Farzana D., Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Wyld, David, Lawrence, Nicola Jane, Stockler, Martin R. and Grimison, Peter S. (2023). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins.
Zebic, Danka Sinikovic, Tran, Ben, Martin, Andrew James, Pashankar, Farzana D., Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Wyld, David, Lawrence, Nicola Jane, Stockler, Martin R., Grimison, Peter S. and Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). 2023 ASCO Annual Meeting, Chicago, IL USA, 2-6 June 2023. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.tps5102
Jefford, Michael, Emery, Jon D., Martin, Andrew James, Lourenco, Richard De Abreu, Lisy, Karolina, Mohamed, Mustafa Abdi, King, Dorothy, Tebbutt, Niall C., Lee, Margaret, Mehrnejad, Ashkan, Burgess, Adele, Marker, Julie, Eggins, Renee, Carrello, Joseph, Thomas, Hayley and Schofield, Penelope (2023). SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Soon, Yu Yang, Marschner, Ian, Hofman, Michael S., Emmett, Louise, Davis, Ian D., Stockler, Martin R. and Martin, Andrew James (2023). Effects of [177Lu] Lu-PSMA-617 on overall survival in TheraP versus VISION randomized trials: An exploratory analysis. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Hayne, Dickon, Stockler, Martin R., Martin, Andrew James, McCombie, Steve P., Zebic, Danka Sinikovic, Bastick, Patricia A., Beardsley, Emma Kate, Frydenberg, Mark, Green, William, Grummet, Jeremy, Hawks, Cynthia, Ischia, Joseph, Mitterdorfer, Andrew, Patel, Manish, Roberts, Matthew, Sengupta, Shomik, Srivastav, Ratnesh Kumar, Redfern, Andrew David and Davis, Ian D. (2023). Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins.
Sandhu, Shahneen, Subramaniam, Shalini, Hofman, Michael S., Stockler, Martin R., Martin, Andrew James, Pokorski, Izabella, Goh, Jeffrey C., Pattison, David A., Dhiantravan, Nattakorn, Gedye, Craig, Rutherford, Natalie K., Joshua, Anthony M., Tan, Thean Hsiang, Kirkwood, Ian D., Lee, Sze Ting, Weickhardt, Andrew James, Alipour, Ramin, Nguyen, Andrew, Davis, Ian D., Emmett, Louise and The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). Evolution: Phase II study of radionuclide 177Lu-PSMA-617 therapy versus 177Lu-PSMA-617 in combination with ipilimumab and nivolumab for men with metastatic castration-resistant prostate cancer (mCRPC; ANZUP 2001). 2023 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 16-18 February 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.6_suppl.tps271
Zebic, Danka, Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Tran, Ben, Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J., Grimison, Peter S. and Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs). 2023 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 16-18 February 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.6_suppl.tps431
Zebic, Danka, Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Ben Tran,, Mazhar, Danish, Huddart, Robert A., Wheater, Matthew, Walpole, Euan Thomas, Dunwoodie, Elaine, Feldman, Darren R., Birtle, Alison Jane, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J. and Grimison, Peter S. (2023). P3BEP (ANZUP 1302): an international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediateand poor-risk metastatic germ cell tumours (GCTs). Genitourinary Cancers Symposium, Virtual, 16-18 February 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins.
Sandhu, Shahneen, Subramaniam, Shalini, Hofman, Michael S., Stockler, Martin R., Martin, Andrew James, Pokorski, Izabella, Goh, Jeffrey C., Pattison, David A., Dhiantravan, Nattakorn, Gedye, Craig, Rutherford, Natalie K., Joshua, Anthony M., Tan, Thean Hsiang, Kirkwood, Ian D., Weickhardt, Andrew James, Lee, Sze Ting, Alipour, Ramin, Nguyen, Andrew, Davis, Ian D. and Emmett, Louise (2023). Evolution:phase II study of radionuclide 177Lu-PSMA-617 therapy versus 177Lu-PSMA617 in combination with ipilimumab and nivolumab for men with metastatic castrationresistant prostate cancer (mCRPC; ANZUP 2001). Genitourinary Cancers Symposium, Virtual, 16-18 February 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins.
Zebic, Danka, Stockler, Martin R., Martin, Andrew, Pashankar, Farzana, Ben Tran,, Mazhar, Danish, Huddart, Robert, Wheater, Matthew, Walpole, Euan, Dunwoodie, Elaine, Feldman, Darren, Birtle, Alison, Stevanovic, Amanda G., Wyld, David, Hanning, Fritha J. and Grimison, Peter S. (2022). P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs). Clinical Oncology Society of Australia (COSA) 49th Annual Scientific Meeting, Brisbane, QLD, Australia, 2-4 November 2022. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13869
Hofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Zhang, Alison Yan, McJannett, Margaret Mary, Stockler, Martin R., Williams, Scott, Martin, Andrew James and Davis, Ian D. (2022). TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Virtual, 3-7 June 2022. Philadelphia, PA USA: Lippincott Williams & Wilkins.
Niazi, Tamim, McBride, Sean Matthew, Williams, Scott, Davis, Ian D., Stockler, Martin R., Martin, Andrew James, Bracken, Karen, Roncolato, Felicia, Horvath, Lisa, Sengupta, Shomik, Martin, Jarad, Lim, Tee, Hughes, Simon, McDermott, Raymond S., Catto, James W. F., Kelly, Paul J., Parulekar, Wendy R., Morgan, Scott Carlyle, Rendon, Ricardo A. and Sweeney, Christopher (2022). DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)-A randomized phase 3, double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Frazier, A. Lindsay, Mazhar, Danish, Ford, Kate, Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Troon, Simon, Hanning, Fritha J., Birtle, Alison Jane, Wheater, Matthew James, Huddart, Robert A., White, Jeff D., Spunt, Sheri L. and Grimison, Peter S. (2020). P3BEP (ANZUP 1302): an international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA USA, 13-15 February 2020. Alexandria, VA: American Society of Clinical Oncology.
Vasista, Anuradha, Martin, Andrew, Pavlakis, Nick, Sjoquist, Katrin M., Snow, Stephanie, Jonker, Derek, Chua, Yu Jo, Epstein, Richard, Bonaventura, Tony, Khasraw, Mustafa, Varma, Suresh, Singhal, Nimit, Ransom, David, Aubin, Francine, Burkes, Ronald, Lim, Howard, Lemay, Frederic, Begbie, Stephen, Stockler, Martin and Kiely, Belinda (2017). Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer. HOBOKEN: WILEY.
Vasista, Anuradha, Martin, Andrew, Pavlakis, Nick, Sjoquist, Katrin M., Goldstein, David, Shapiro, Jeremy, Karapetis, Chris, Gill, Sanjeev, Jain, Vikram, Liu, Geoffrey, Kannourakis, George, Kim, Yeul Hong, Wigston (Nott), Louise, Snow, Stephanie, Harris, Dean, Jonker, Derek, Chua, Yu Jo, Stockler, Martin and Kiely, Belinda (2017). Can Time to Progression on Last Line Treatment Inform us About Post-Progression Survival Time in Advanced Gastric Cancer?. HOBOKEN: WILEY.
Wong, Nicole, Nayar, Namrata, Lawrence, Nicola, Stockler, Martin, Martin, Andrew, Yip, Sonia, Yeung, Annie, Friedlander, Michael, Mazhar, Danish, Pashankar, Farzana, Quinn, David, Walker, Roderick, Winstanley, Mark, Weickhardt, Andrew, Hanning, Fritha, Stevanovic, Amanda, Davis, Ian, Toner, Guy and Grimison, Peter (2017). P3BEP (ANZUP 1302): An International Randomised Phase III Trial of Accelerated Versus Standard BEP Chemotherapy for Adult and Pediatric Male and Female Patients With Intermediate and Poor-Risk Metastatic Germ Cell Tumours (GCTS). HOBOKEN: WILEY.
Yee, Jasmine, Davis, Glen M., Hackett, Daniel, Beith, Janem M., Wilcken, Nicholas, Currow, David, Emery, Jon, Phillips, Jane, Martin, Andrew, Hui, Rina, Harrison, Michelle, Segelov, Eva and Kilbreath, Sharon L. (2017). Physical Activity for Women with Metastatic Breast Cancer: A Pilot RCT. HOBOKEN: WILEY.
Moth, Erin B., Kiely, Belinda E., Naganathan, Vasikaran, Martin, Andrew, Stefanic, Natalie, Beale, Philip, Grimison, Peter and Blinman, Prunella (2017). Predicting Chemotherapy Toxicity in Older Adults: Comparing the Value of the Carg Toxicity Score With Oncologists' Estimates of Toxicity. HOBOKEN: WILEY.
Emery, Jon, Murray, Sonya, Campbell, Neil, Walter, Fiiona M., Mazza, Danielle, Habgood, Emily, Kutzer, Yvonne, Martin, Andrew, Goodall, Stephen, Barnes, David and Murchie, Peter (2017). The Chest Australia Trial: A Phase II Randomised Controlled Trial of an Intervention to Reduce Time to Consult with Symptoms of Lung Cancer. HOBOKEN: WILEY.
Lawrence, N. J., Martin, A., Davis, I. D., Troon, S., Sengupta, S., Hovey, E. J., Coskinas, X., Kaplan, R., Ritchie, A. W. S., Meade, A., Eisen, T., Blinman, P. and Stockler, M. R. (2017). Predicted benefits of adjuvant sorafenib after nephrectomy for renal cell carcinoma (RCC) in SORCE: an international, placebo-controlled, randomised phase 3 trial. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid Spain, Sep 08-12, 2017. OXFORD: OXFORD UNIV PRESS.
Martin, Andrew (2017). USING TRIAL INFRASTRUCTURE EFFICIENTLY: PLATFORM, FACTORIAL, AND UMBRELLA TRIAL DESIGNS. HOBOKEN: WILEY.
Stockler, Martin, Whitford, Hayley S., Kalinowski, Pawel, Schembri, Adrian, Toner, Guy, Grimison, Peter, Martin, Andrew, Davis, Ian, Wong, Nicole and Olver, Ian (2016). A PROSPECTIVE, LONGITUDINAL COHORT STUDY TO INVESTIGATE THE IMPACT OF CHEMOTHERAPY ON COGNITION IN TESTICULAR CANCER. HOBOKEN: WILEY-BLACKWELL.
Lawrence, Nicola, Martin, Andrew, Toner, Guy, Stockler, Martin, Buizen, Luke, Thomson, Damien, Gebski, Val, Friedlander, Michael, Yeung, Annie, Gurney, Howard, Rosenthal, Mark, Singhal, Nimit, Kichenadasse, Ganessan, Wong, Shirley, Lewis, Craig, Vasey, Paul and Grimison, Peter (2016). LONG-TERM OUTCOMES OF ACCELERATED BEP (BLEOMYCIN, ETOPOSIDE, CISPLATIN) FOR ADVANCED GERM-CELL TUMORS: UPDATED ANALYSIS OF AN AUSTRALIAN MULTICENTER PHASE II TRIAL. HOBOKEN: WILEY-BLACKWELL.
Gao, Jing, Martin, Andrew, Yatvin, Jeremy and Locklin, Jason (2016). Permanently grafted abrasion resistant nanocomposites for anti-icing applications. WASHINGTON: AMER CHEMICAL SOC.
Martin, Andrew (2015). ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS. HOBOKEN: WILEY-BLACKWELL.
Grummet, Jeremy, Davis, Ian, Martin, Andrew, Buchan, Nicholas, Chalasani, Venu, Frydenberg, Mark, Hayne, Dickon, Lalak, Andre, Patel, Manish, Williams, Andrew, Woo, Henry, Lawrence, Nicola, Chan, Howard, Bishop, Claudia, Wong, Nicole, Coskinas, Xanthi and Stockler, Martin (2015). RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501. HOBOKEN: WILEY-BLACKWELL.
Williams, Scott G., Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Long, Anne, Yip, Sonia, Tu, Emily, Chan, Howard, Lawrence, Nicky, McDermott, Ray, Hughes, Simon, Marchesin, Vittorio, Deignan, Olwyn and Nguyen, Paul L. (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303). HOBOKEN: WILEY-BLACKWELL.
Davis, Ian, Stockler, Martin, Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Dazo, Carlo, Long, Anne, Lawrence, Nicky, Chan, Howard, McDermott, Ray, Chowdhury, Simon, Marchesin, Vittorio, Deignan, Olwyn, Parulekar, Wendy, Suris, Alexander Montenegro and Sweeney, Christopher (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304). HOBOKEN: WILEY-BLACKWELL.
Chalasani, Venu, Sengupta, Shomik, Stockler, Martin, McCombie, Steve, Hawks, Cynthia, Krieger, Laurence, Anderson, Paul, Grummet, Jeremy, Mitterdorfer, Andrew J., Bishop, Conrad, Beardsley, Emma, Martin, Andrew, Lawrence, Nicola, Wong, Nicole, Chan, Howard, Pysarenko, Mariya, Harper, Matthew, Patel, Manish, Hamid, Akil, Davis, Ian and Hayne, Dickon (2015). RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301). HOBOKEN: WILEY-BLACKWELL.
Karikios, D., Mileshkin, L., Martin, A., Ferraro, D. and Stockler, M. (2015). Discussing and prescribing expensive unfunded anticancer drugs in Australia. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(16)30506-8
Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2
Emery, Jon, Schofield, Penny, Jefford, Michael, King, Madeleine, Pirotta, Marie, Hayne, Dickon, Martin, Andrew, Trevena, Lyndal, Lim, Tee and Constable, Roger (2014). THE PROCARE TRIAL: A PHASE II RANDOMISED CONTROLLED TRIAL OF SHARED CARE FOR FOLLOW-UP OF MEN WITH PROSTATE CANCER. HOBOKEN: WILEY-BLACKWELL.
Rodrigo, Natassia, Wong, Vivien, Shek, Ka Lai, Martin, Andrew and Dietz, Hans Peter (2014). The use of 3-dimensional ultrasound of the pelvic floor to predict recurrence risk after pelvic reconstructive surgery. Blackwell Publishing. doi: 10.1111/ajo.12171
Kiely, Belinda E., Martin, Andrew J., Tattersall, Martin H. N., Nowak, Anna K., Goldstein, David, Wilcken, Nicholas, Wyld, David, Beale, Philip James, Jefford, Michael, Glasgow, Amanda L., Abdi, Ehtesham A., Glare, Paul A. and Stockler, Martin R. (2012). Usefulness of medical oncologists' estimates of survival time in people with advanced cancer. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 1-6 June 2012. Alexandria, VA USA: American Society of Clinical Oncology.